Finance

Lists
AVG:ETR
Avantor Inc
€11.86
+0.25%
(+0.030) 1D
Aug 11, 5:35:41 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AVG...
Open
€11.86
High
€11.86
Low
€11.86
Mkt. cap
9.31B
Avg. vol.
49.00
Volume
0.00
52-wk high
€12.27
52-wk low
€8.20
No. of employees
14K
Open
€11.86
High
€11.86
Low
€11.86
Mkt. cap
9.31B
Avg. vol.
49.00
Volume
0.00
52-wk high
€12.27
52-wk low
€8.20
No. of employees
14K
News stories
From web sources and news partners
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEOEmmanuel Ligner
Employees13.5K
Founded1904
HeadquartersRadnor Township, Pennsylvania, United States
SectorHealth care
Websiteavantorsciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.62B
1.66B
1.58B
1.69B
Cost of goods sold
1.10B
1.14B
1.08B
1.16B
Cost of revenue
1.10B
1.14B
1.08B
1.16B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
388.80M
338.40M
401.70M
415.80M
Operating expense
388.80M
338.40M
401.70M
415.80M
Total operating expenses
1.49B
1.48B
1.48B
1.57B
Operating income
137.70M
185.50M
99.00M
121.20M
Other non operating income
700.00K
-7.00M
-
100.00K
EBT including unusual items
-689.50M
80.80M
55.50M
81.20M
EBT excluding unusual items
95.70M
136.40M
56.10M
81.80M
Income tax expense
22.30M
28.40M
12.20M
43.10M
Effective tax rate
-3.23%
35.15%
21.98%
53.08%
Other operating expenses
-
-
-
-
Net income
-711.80M
52.40M
43.30M
38.10M
Net profit margin
-43.84%
3.15%
2.74%
2.25%
Earnings per share
0.22
0.22
0.17
0.21
Interest and investment income
11.90M
11.40M
10.50M
10.30M
Interest expense
-58.00M
-53.40M
-53.40M
-49.70M
Net interest expenses
-46.10M
-42.00M
-42.90M
-39.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
242.20M
288.80M
204.00M
226.80M
Gain or loss from assets sale
-
5.10M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps